nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—CHRM3—Amitriptyline—migraine	0.353	0.555	CbGbCtD
Mivacurium—CHRM2—Amitriptyline—migraine	0.284	0.445	CbGbCtD
Mivacurium—Hypoxia—Gabapentin—migraine	0.00658	0.0319	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Propranolol—migraine	0.0058	0.0281	CcSEcCtD
Mivacurium—Injection site reaction—Valproic Acid—migraine	0.00502	0.0243	CcSEcCtD
Mivacurium—Bronchospasm—Propranolol—migraine	0.00477	0.0232	CcSEcCtD
Mivacurium—Bronchospasm—Verapamil—migraine	0.00439	0.0213	CcSEcCtD
Mivacurium—Arrhythmia—Amitriptyline—migraine	0.00426	0.0207	CcSEcCtD
Mivacurium—CHRND—Neuronal System—KCNK18—migraine	0.00407	0.0272	CbGpPWpGaD
Mivacurium—Bradycardia—Propranolol—migraine	0.00396	0.0192	CcSEcCtD
Mivacurium—Bradycardia—Verapamil—migraine	0.00364	0.0176	CcSEcCtD
Mivacurium—CHRM3—Monoamine GPCRs—HTR1D—migraine	0.00361	0.0241	CbGpPWpGaD
Mivacurium—Cardiac disorder—Propranolol—migraine	0.00361	0.0175	CcSEcCtD
Mivacurium—CHRM2—Monoamine GPCRs—HTR1D—migraine	0.00357	0.0239	CbGpPWpGaD
Mivacurium—Phlebitis—Gabapentin—migraine	0.00352	0.0171	CcSEcCtD
Mivacurium—CHRNA1—Neuronal System—KCNK18—migraine	0.00346	0.0232	CbGpPWpGaD
Mivacurium—Erythema—Propranolol—migraine	0.00338	0.0164	CcSEcCtD
Mivacurium—CHRM3—Monoamine GPCRs—HTR2B—migraine	0.00335	0.0224	CbGpPWpGaD
Mivacurium—CHRM2—Monoamine GPCRs—HTR2B—migraine	0.00332	0.0222	CbGpPWpGaD
Mivacurium—Flushing—Verapamil—migraine	0.00332	0.0161	CcSEcCtD
Mivacurium—Tachycardia—Amitriptyline—migraine	0.00331	0.0161	CcSEcCtD
Mivacurium—CHRNA2—Neuronal System—KCNK18—migraine	0.00329	0.022	CbGpPWpGaD
Mivacurium—Hypotension—Amitriptyline—migraine	0.00317	0.0154	CcSEcCtD
Mivacurium—CHRM3—Amine ligand-binding receptors—HTR1D—migraine	0.00303	0.0203	CbGpPWpGaD
Mivacurium—CHRM2—Amine ligand-binding receptors—HTR1D—migraine	0.003	0.0201	CbGpPWpGaD
Mivacurium—Muscle spasms—Verapamil—migraine	0.00299	0.0145	CcSEcCtD
Mivacurium—Phlebitis—Topiramate—migraine	0.00297	0.0144	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00286	0.0139	CcSEcCtD
Mivacurium—CHRM3—Amine ligand-binding receptors—HTR2B—migraine	0.00282	0.0189	CbGpPWpGaD
Mivacurium—CHRM2—Amine ligand-binding receptors—HTR2B—migraine	0.00279	0.0187	CbGpPWpGaD
Mivacurium—Bronchospasm—Timolol—migraine	0.00277	0.0134	CcSEcCtD
Mivacurium—Anaphylactic shock—Propranolol—migraine	0.00276	0.0134	CcSEcCtD
Mivacurium—Urticaria—Amitriptyline—migraine	0.00269	0.0131	CcSEcCtD
Mivacurium—Skin disorder—Propranolol—migraine	0.00268	0.013	CcSEcCtD
Mivacurium—CHRND—Transmission across Chemical Synapses—CACNA1A—migraine	0.0026	0.0174	CbGpPWpGaD
Mivacurium—Bronchospasm—Gabapentin—migraine	0.00258	0.0125	CcSEcCtD
Mivacurium—Bradycardia—Valproic Acid—migraine	0.00258	0.0125	CcSEcCtD
Mivacurium—Anaphylactic shock—Verapamil—migraine	0.00254	0.0123	CcSEcCtD
Mivacurium—Tachycardia—Verapamil—migraine	0.00248	0.012	CcSEcCtD
Mivacurium—Hypotension—Verapamil—migraine	0.00237	0.0115	CcSEcCtD
Mivacurium—Angiopathy—Valproic Acid—migraine	0.0023	0.0112	CcSEcCtD
Mivacurium—Bradycardia—Timolol—migraine	0.0023	0.0111	CcSEcCtD
Mivacurium—Immune system disorder—Valproic Acid—migraine	0.00229	0.0111	CcSEcCtD
Mivacurium—Mediastinal disorder—Valproic Acid—migraine	0.00228	0.0111	CcSEcCtD
Mivacurium—Arrhythmia—Valproic Acid—migraine	0.00226	0.011	CcSEcCtD
Mivacurium—Dizziness—Amitriptyline—migraine	0.00224	0.0109	CcSEcCtD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—CACNA1A—migraine	0.00221	0.0148	CbGpPWpGaD
Mivacurium—Urticaria—Propranolol—migraine	0.00219	0.0106	CcSEcCtD
Mivacurium—CHRM3—Monoamine GPCRs—HTR1B—migraine	0.00219	0.0146	CbGpPWpGaD
Mivacurium—CHRM2—Monoamine GPCRs—HTR1B—migraine	0.00216	0.0145	CbGpPWpGaD
Mivacurium—Bradycardia—Gabapentin—migraine	0.00214	0.0104	CcSEcCtD
Mivacurium—Rash—Amitriptyline—migraine	0.00214	0.0104	CcSEcCtD
Mivacurium—Dermatitis—Amitriptyline—migraine	0.00214	0.0104	CcSEcCtD
Mivacurium—Muscle spasms—Valproic Acid—migraine	0.00212	0.0103	CcSEcCtD
Mivacurium—CHRM3—Monoamine GPCRs—HTR1A—migraine	0.0021	0.0141	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—CACNA1A—migraine	0.0021	0.014	CbGpPWpGaD
Mivacurium—Cardiac disorder—Timolol—migraine	0.00209	0.0102	CcSEcCtD
Mivacurium—CHRM2—Monoamine GPCRs—HTR1A—migraine	0.00208	0.0139	CbGpPWpGaD
Mivacurium—CHRNA1—ErbB2/ErbB3 signaling events—FOS—migraine	0.00208	0.0139	CbGpPWpGaD
Mivacurium—Angiopathy—Timolol—migraine	0.00205	0.00993	CcSEcCtD
Mivacurium—Immune system disorder—Timolol—migraine	0.00204	0.00988	CcSEcCtD
Mivacurium—Mediastinal disorder—Timolol—migraine	0.00203	0.00986	CcSEcCtD
Mivacurium—CHRM3—Monoamine GPCRs—HTR2C—migraine	0.00203	0.0136	CbGpPWpGaD
Mivacurium—Urticaria—Verapamil—migraine	0.00202	0.00979	CcSEcCtD
Mivacurium—Arrhythmia—Timolol—migraine	0.00202	0.00978	CcSEcCtD
Mivacurium—CHRM2—Monoamine GPCRs—HTR2C—migraine	0.00201	0.0135	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—CACNA1A—migraine	0.00199	0.0133	CbGpPWpGaD
Mivacurium—Erythema—Timolol—migraine	0.00196	0.00953	CcSEcCtD
Mivacurium—Cardiac disorder—Gabapentin—migraine	0.00195	0.00946	CcSEcCtD
Mivacurium—CHRM3—Regulation of insulin secretion—CACNA1A—migraine	0.00191	0.0128	CbGpPWpGaD
Mivacurium—Immune system disorder—Gabapentin—migraine	0.0019	0.0092	CcSEcCtD
Mivacurium—Mediastinal disorder—Gabapentin—migraine	0.00189	0.00918	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00187	0.00905	CcSEcCtD
Mivacurium—CHRM3—Amine ligand-binding receptors—HTR1B—migraine	0.00184	0.0123	CbGpPWpGaD
Mivacurium—Erythema—Gabapentin—migraine	0.00183	0.00887	CcSEcCtD
Mivacurium—Dizziness—Propranolol—migraine	0.00183	0.00885	CcSEcCtD
Mivacurium—CHRM2—Amine ligand-binding receptors—HTR1B—migraine	0.00182	0.0122	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—KCNK18—migraine	0.00182	0.0121	CbGpPWpGaD
Mivacurium—Anaphylactic shock—Valproic Acid—migraine	0.0018	0.00873	CcSEcCtD
Mivacurium—Bradycardia—Topiramate—migraine	0.0018	0.00873	CcSEcCtD
Mivacurium—CHRM3—Monoamine GPCRs—HTR7—migraine	0.00178	0.0119	CbGpPWpGaD
Mivacurium—CHRM3—Amine ligand-binding receptors—HTR1A—migraine	0.00177	0.0118	CbGpPWpGaD
Mivacurium—CHRM2—Monoamine GPCRs—HTR7—migraine	0.00176	0.0118	CbGpPWpGaD
Mivacurium—Muscle spasms—Gabapentin—migraine	0.00176	0.00853	CcSEcCtD
Mivacurium—Tachycardia—Valproic Acid—migraine	0.00176	0.00852	CcSEcCtD
Mivacurium—CHRM2—Amine ligand-binding receptors—HTR1A—migraine	0.00175	0.0117	CbGpPWpGaD
Mivacurium—Skin disorder—Valproic Acid—migraine	0.00175	0.00848	CcSEcCtD
Mivacurium—Rash—Propranolol—migraine	0.00174	0.00844	CcSEcCtD
Mivacurium—Dermatitis—Propranolol—migraine	0.00174	0.00843	CcSEcCtD
Mivacurium—CHRM3—Amine ligand-binding receptors—HTR2C—migraine	0.00171	0.0114	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—CACNA1A—migraine	0.00169	0.0113	CbGpPWpGaD
Mivacurium—CHRM2—Amine ligand-binding receptors—HTR2C—migraine	0.00169	0.0113	CbGpPWpGaD
Mivacurium—Hypotension—Valproic Acid—migraine	0.00168	0.00816	CcSEcCtD
Mivacurium—Dizziness—Verapamil—migraine	0.00168	0.00815	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00166	0.00805	CcSEcCtD
Mivacurium—Flushing—Topiramate—migraine	0.00164	0.00796	CcSEcCtD
Mivacurium—Cardiac disorder—Topiramate—migraine	0.00164	0.00796	CcSEcCtD
Mivacurium—CHRNA2—Neuronal System—CACNA1A—migraine	0.00161	0.0107	CbGpPWpGaD
Mivacurium—Angiopathy—Topiramate—migraine	0.0016	0.00778	CcSEcCtD
Mivacurium—Anaphylactic shock—Timolol—migraine	0.0016	0.00777	CcSEcCtD
Mivacurium—Rash—Verapamil—migraine	0.0016	0.00777	CcSEcCtD
Mivacurium—Dermatitis—Verapamil—migraine	0.0016	0.00776	CcSEcCtD
Mivacurium—Immune system disorder—Topiramate—migraine	0.0016	0.00774	CcSEcCtD
Mivacurium—Mediastinal disorder—Topiramate—migraine	0.00159	0.00773	CcSEcCtD
Mivacurium—Skin disorder—Timolol—migraine	0.00156	0.00755	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00155	0.0075	CcSEcCtD
Mivacurium—Erythema—Topiramate—migraine	0.00154	0.00746	CcSEcCtD
Mivacurium—CHRM3—Integration of energy metabolism—CACNA1A—migraine	0.0015	0.01	CbGpPWpGaD
Mivacurium—Hypotension—Timolol—migraine	0.0015	0.00726	CcSEcCtD
Mivacurium—CHRM3—Amine ligand-binding receptors—HTR7—migraine	0.0015	0.01	CbGpPWpGaD
Mivacurium—Anaphylactic shock—Gabapentin—migraine	0.00149	0.00724	CcSEcCtD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00149	0.00995	CbGpPWpGaD
Mivacurium—CHRM2—Amine ligand-binding receptors—HTR7—migraine	0.00148	0.00991	CbGpPWpGaD
Mivacurium—Muscle spasms—Topiramate—migraine	0.00148	0.00718	CcSEcCtD
Mivacurium—Tachycardia—Gabapentin—migraine	0.00146	0.00707	CcSEcCtD
Mivacurium—Skin disorder—Gabapentin—migraine	0.00145	0.00703	CcSEcCtD
Mivacurium—Urticaria—Valproic Acid—migraine	0.00143	0.00694	CcSEcCtD
Mivacurium—Hypotension—Gabapentin—migraine	0.00139	0.00677	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.0013	0.00631	CcSEcCtD
Mivacurium—Urticaria—Timolol—migraine	0.00127	0.00618	CcSEcCtD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—HTR3A—migraine	0.00126	0.00846	CbGpPWpGaD
Mivacurium—CHRM3—Monoamine GPCRs—HTR2A—migraine	0.00125	0.00834	CbGpPWpGaD
Mivacurium—CHRM2—Monoamine GPCRs—HTR2A—migraine	0.00123	0.00825	CbGpPWpGaD
Mivacurium—Tachycardia—Topiramate—migraine	0.00123	0.00594	CcSEcCtD
Mivacurium—Skin disorder—Topiramate—migraine	0.00122	0.00592	CcSEcCtD
Mivacurium—Dizziness—Valproic Acid—migraine	0.00119	0.00578	CcSEcCtD
Mivacurium—Urticaria—Gabapentin—migraine	0.00119	0.00575	CcSEcCtD
Mivacurium—Hypotension—Topiramate—migraine	0.00117	0.00569	CcSEcCtD
Mivacurium—BCHE—Transmission across Chemical Synapses—CACNA1A—migraine	0.00116	0.00774	CbGpPWpGaD
Mivacurium—BCHE—Peptide hormone metabolism—ACE—migraine	0.00114	0.00761	CbGpPWpGaD
Mivacurium—Rash—Valproic Acid—migraine	0.00114	0.00551	CcSEcCtD
Mivacurium—Dermatitis—Valproic Acid—migraine	0.00113	0.0055	CcSEcCtD
Mivacurium—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.00113	0.00753	CbGpPWpGaD
Mivacurium—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.00112	0.00746	CbGpPWpGaD
Mivacurium—Dizziness—Timolol—migraine	0.00106	0.00514	CcSEcCtD
Mivacurium—CHRM3—Amine ligand-binding receptors—HTR2A—migraine	0.00105	0.00701	CbGpPWpGaD
Mivacurium—CHRM2—Amine ligand-binding receptors—HTR2A—migraine	0.00104	0.00694	CbGpPWpGaD
Mivacurium—Rash—Timolol—migraine	0.00101	0.0049	CcSEcCtD
Mivacurium—Dermatitis—Timolol—migraine	0.00101	0.0049	CcSEcCtD
Mivacurium—Urticaria—Topiramate—migraine	0.000997	0.00484	CcSEcCtD
Mivacurium—Dizziness—Gabapentin—migraine	0.000987	0.00479	CcSEcCtD
Mivacurium—Rash—Gabapentin—migraine	0.000941	0.00456	CcSEcCtD
Mivacurium—Dermatitis—Gabapentin—migraine	0.00094	0.00456	CcSEcCtD
Mivacurium—BCHE—Neuronal System—CACNA1A—migraine	0.000887	0.00593	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Other—EDNRA—migraine	0.000878	0.00587	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Other—EDNRA—migraine	0.000869	0.00581	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—HTR2B—migraine	0.000837	0.0056	CbGpPWpGaD
Mivacurium—Dizziness—Topiramate—migraine	0.00083	0.00403	CcSEcCtD
Mivacurium—CHRND—cardiovascular system—migraine	0.000794	0.108	CbGeAlD
Mivacurium—Rash—Topiramate—migraine	0.000792	0.00384	CcSEcCtD
Mivacurium—Dermatitis—Topiramate—migraine	0.000791	0.00384	CcSEcCtD
Mivacurium—CHRM3—GPCRs, Other—HTR7—migraine	0.00079	0.00529	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Other—HTR7—migraine	0.000783	0.00524	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000749	0.00501	CbGpPWpGaD
Mivacurium—CHRM2—G alpha (i) signalling events—HTR1D—migraine	0.000743	0.00497	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000696	0.00466	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000689	0.00461	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000647	0.00433	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000641	0.00429	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CALCRL—migraine	0.000625	0.00418	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—RAMP1—migraine	0.000625	0.00418	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—RAMP1—migraine	0.000619	0.00414	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CALCRL—migraine	0.000619	0.00414	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—HTR1A—migraine	0.000601	0.00402	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000596	0.00399	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—TAC1—migraine	0.000592	0.00396	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000591	0.00395	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000581	0.00388	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000554	0.00371	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Other—HTR2A—migraine	0.000554	0.0037	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000549	0.00367	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Other—HTR2A—migraine	0.000548	0.00367	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—NPS—migraine	0.000517	0.00346	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—TAC1—migraine	0.000517	0.00346	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—HTR2C—migraine	0.000507	0.00339	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—EDNRA—migraine	0.000493	0.0033	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000463	0.00309	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000463	0.00309	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—HTR1D—migraine	0.000454	0.00304	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000454	0.00303	CbGpPWpGaD
Mivacurium—CHRM2—G alpha (i) signalling events—HTR1B—migraine	0.00045	0.00301	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—HTR1D—migraine	0.00045	0.00301	CbGpPWpGaD
Mivacurium—CHRNA1—head—migraine	0.000449	0.0609	CbGeAlD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000441	0.00295	CbGpPWpGaD
Mivacurium—CHRM2—G alpha (i) signalling events—HTR1A—migraine	0.000433	0.0029	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—HTR2B—migraine	0.000422	0.00282	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000422	0.00282	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—BDNF—migraine	0.000422	0.00282	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—HTR2B—migraine	0.000418	0.0028	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000418	0.00279	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000406	0.00272	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000402	0.00269	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000392	0.00262	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000388	0.0026	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000381	0.00255	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000378	0.00253	CbGpPWpGaD
Mivacurium—CHRNA2—head—migraine	0.000372	0.0506	CbGeAlD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000361	0.00242	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000358	0.00239	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—HTR2A—migraine	0.000356	0.00238	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—RAMP1—migraine	0.000353	0.00236	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CALCRL—migraine	0.000353	0.00236	CbGpPWpGaD
Mivacurium—CHRNA2—nervous system—migraine	0.000353	0.0479	CbGeAlD
Mivacurium—CHRM2—GPCR downstream signaling—CALCRL—migraine	0.00035	0.00234	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—RAMP1—migraine	0.00035	0.00234	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000348	0.00233	CbGpPWpGaD
Mivacurium—CHRNB1—head—migraine	0.000346	0.047	CbGeAlD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000344	0.0023	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000343	0.0023	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000343	0.00229	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000343	0.00229	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00034	0.00227	CbGpPWpGaD
Mivacurium—CHRNA2—central nervous system—migraine	0.00034	0.0462	CbGeAlD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000339	0.00227	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000339	0.00227	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000336	0.00225	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000333	0.00222	CbGpPWpGaD
Mivacurium—CHRNA2—cerebellum—migraine	0.000332	0.0451	CbGeAlD
Mivacurium—CHRM2—cardiovascular system—migraine	0.000328	0.0445	CbGeAlD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000327	0.00219	CbGpPWpGaD
Mivacurium—CHRNA1—brain—migraine	0.000325	0.0442	CbGeAlD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000324	0.00216	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—RAMP1—migraine	0.000321	0.00215	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CALCRL—migraine	0.000321	0.00215	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CALCRL—migraine	0.000318	0.00212	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—RAMP1—migraine	0.000318	0.00212	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—HTR2A—migraine	0.000311	0.00208	CbGpPWpGaD
Mivacurium—CHRNB1—cerebellum—migraine	0.000309	0.042	CbGeAlD
Mivacurium—BCHE—trigeminal ganglion—migraine	0.000302	0.041	CbGeAlD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000294	0.00197	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000291	0.00195	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000278	0.00186	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—HTR1B—migraine	0.000275	0.00184	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—HTR1B—migraine	0.000272	0.00182	CbGpPWpGaD
Mivacurium—CHRNA2—brain—migraine	0.00027	0.0366	CbGeAlD
Mivacurium—BCHE—brainstem—migraine	0.000267	0.0363	CbGeAlD
Mivacurium—CHRM3—GPCR ligand binding—HTR1A—migraine	0.000265	0.00177	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—HTR1A—migraine	0.000262	0.00175	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—NPS—migraine	0.000261	0.00174	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—TAC1—migraine	0.000261	0.00174	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—TAC1—migraine	0.000258	0.00173	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—NPS—migraine	0.000258	0.00173	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—HTR1D—migraine	0.000257	0.00172	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—HTR2C—migraine	0.000256	0.00171	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR1D—migraine	0.000254	0.0017	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—HTR2C—migraine	0.000253	0.00169	CbGpPWpGaD
Mivacurium—CHRNB1—brain—migraine	0.000251	0.0341	CbGeAlD
Mivacurium—CHRM3—GPCR ligand binding—EDNRA—migraine	0.000249	0.00166	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—EDNRA—migraine	0.000246	0.00165	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000241	0.00161	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CALCA—migraine	0.00024	0.0016	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—HTR2B—migraine	0.000239	0.0016	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000238	0.00159	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CALCA—migraine	0.000237	0.00159	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR2B—migraine	0.000236	0.00158	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR1D—migraine	0.000233	0.00156	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HTR1D—migraine	0.000231	0.00154	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—HTR7—migraine	0.000224	0.0015	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CACNA1A—migraine	0.000223	0.00149	CbGpPWpGaD
Mivacurium—CHRM2—head—migraine	0.000222	0.0302	CbGeAlD
Mivacurium—CHRM2—GPCR ligand binding—HTR7—migraine	0.000222	0.00148	CbGpPWpGaD
Mivacurium—BCHE—cardiovascular system—migraine	0.000218	0.0296	CbGeAlD
Mivacurium—CHRM3—Signaling by GPCR—HTR2B—migraine	0.000217	0.00145	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—ACE—migraine	0.000215	0.00144	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HTR2B—migraine	0.000215	0.00144	CbGpPWpGaD
Mivacurium—CHRM2—nervous system—migraine	0.00021	0.0286	CbGeAlD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000206	0.00138	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000204	0.00136	CbGpPWpGaD
Mivacurium—CHRM2—central nervous system—migraine	0.000203	0.0275	CbGeAlD
Mivacurium—CHRM3—Signaling Pathways—CALCRL—migraine	0.000189	0.00127	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RAMP1—migraine	0.000189	0.00127	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RAMP1—migraine	0.000188	0.00125	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CALCRL—migraine	0.000188	0.00125	CbGpPWpGaD
Mivacurium—CHRM3—head—migraine	0.000181	0.0246	CbGeAlD
Mivacurium—CHRM3—Metabolism—CACNA1A—migraine	0.000172	0.00115	CbGpPWpGaD
Mivacurium—CHRM3—nervous system—migraine	0.000171	0.0233	CbGeAlD
Mivacurium—CHRM3—central nervous system—migraine	0.000165	0.0224	CbGeAlD
Mivacurium—CHRM2—brain—migraine	0.000161	0.0219	CbGeAlD
Mivacurium—CHRM3—GPCR ligand binding—HTR2A—migraine	0.000157	0.00105	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—HTR1B—migraine	0.000156	0.00104	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—HTR2A—migraine	0.000155	0.00104	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR1B—migraine	0.000154	0.00103	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—TNF—migraine	0.000153	0.00102	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—HTR1A—migraine	0.00015	0.001	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR1A—migraine	0.000148	0.000991	CbGpPWpGaD
Mivacurium—BCHE—head—migraine	0.000148	0.02	CbGeAlD
Mivacurium—CHRM3—GPCR downstream signaling—TAC1—migraine	0.000147	0.000986	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—NPS—migraine	0.000147	0.000986	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—TAC1—migraine	0.000146	0.000976	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—NPS—migraine	0.000146	0.000976	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—HTR2C—migraine	0.000145	0.000967	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR2C—migraine	0.000143	0.000957	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR1B—migraine	0.000141	0.000944	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—EDNRA—migraine	0.000141	0.00094	CbGpPWpGaD
Mivacurium—BCHE—nervous system—migraine	0.00014	0.019	CbGeAlD
Mivacurium—CHRM2—Signaling by GPCR—HTR1B—migraine	0.00014	0.000935	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—EDNRA—migraine	0.000139	0.000931	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR1D—migraine	0.000138	0.000921	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR1D—migraine	0.000136	0.000912	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR1A—migraine	0.000136	0.000909	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CALCA—migraine	0.000135	0.000905	CbGpPWpGaD
Mivacurium—BCHE—central nervous system—migraine	0.000135	0.0183	CbGeAlD
Mivacurium—CHRM2—Signaling by GPCR—HTR1A—migraine	0.000135	0.0009	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CALCA—migraine	0.000134	0.000897	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—NPS—migraine	0.000134	0.000895	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—TAC1—migraine	0.000134	0.000895	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—TAC1—migraine	0.000133	0.000887	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—NPS—migraine	0.000133	0.000887	CbGpPWpGaD
Mivacurium—BCHE—cerebellum—migraine	0.000132	0.0179	CbGeAlD
Mivacurium—CHRM3—Signaling by GPCR—HTR2C—migraine	0.000131	0.000878	CbGpPWpGaD
Mivacurium—CHRM3—brain—migraine	0.000131	0.0178	CbGeAlD
Mivacurium—CHRM2—Signaling by GPCR—HTR2C—migraine	0.00013	0.000869	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR2B—migraine	0.000128	0.000856	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EDNRA—migraine	0.000128	0.000854	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR2B—migraine	0.000127	0.000848	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—HTR7—migraine	0.000127	0.000847	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EDNRA—migraine	0.000126	0.000846	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR7—migraine	0.000125	0.000839	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CALCA—migraine	0.000123	0.000822	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CALCA—migraine	0.000122	0.000814	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR7—migraine	0.000115	0.000769	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HTR7—migraine	0.000114	0.000762	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LRP1—migraine	0.000113	0.000754	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LRP1—migraine	0.000112	0.000746	CbGpPWpGaD
Mivacurium—BCHE—brain—migraine	0.000107	0.0145	CbGeAlD
Mivacurium—CHRM3—GPCR downstream signaling—HTR2A—migraine	8.87e-05	0.000593	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—HTR2A—migraine	8.78e-05	0.000587	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH4—migraine	8.65e-05	0.000578	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH4—migraine	8.56e-05	0.000573	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR1B—migraine	8.34e-05	0.000558	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR1B—migraine	8.26e-05	0.000552	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR2A—migraine	8.05e-05	0.000539	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR1A—migraine	8.03e-05	0.000537	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HTR2A—migraine	7.98e-05	0.000533	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR1A—migraine	7.95e-05	0.000532	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NPS—migraine	7.91e-05	0.000529	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TAC1—migraine	7.91e-05	0.000529	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PGR—migraine	7.91e-05	0.000529	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NPS—migraine	7.83e-05	0.000524	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PGR—migraine	7.83e-05	0.000524	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TAC1—migraine	7.83e-05	0.000524	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR2C—migraine	7.76e-05	0.000519	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR2C—migraine	7.68e-05	0.000514	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDNRA—migraine	7.54e-05	0.000505	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDNRA—migraine	7.47e-05	0.0005	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—MTHFR—migraine	7.39e-05	0.000494	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH3—migraine	7.35e-05	0.000492	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH3—migraine	7.28e-05	0.000487	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CALCA—migraine	7.26e-05	0.000486	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CALCA—migraine	7.19e-05	0.000481	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR7—migraine	6.79e-05	0.000454	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR7—migraine	6.73e-05	0.00045	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFBR2—migraine	5.85e-05	0.000391	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFBR2—migraine	5.79e-05	0.000387	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MTHFR—migraine	5.68e-05	0.00038	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR2A—migraine	4.76e-05	0.000318	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR2A—migraine	4.71e-05	0.000315	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ESR1—migraine	4.22e-05	0.000282	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ESR1—migraine	4.18e-05	0.00028	CbGpPWpGaD
